Moore John R
General Counsel
1 company
Insider Signal Score
45
WeakTrades Analyzed
28
12M Win Rate
29.6%
Avg 3M Return
-34.3%
Avg 12M Return
-28.0%
Moore John R is a General Counsel at Edgewise Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $457K based on current market prices.
Holdings by Company
EWTXAug 12, 2025
Current Shares12.3K
Value$456.9K
Net Activity-324,760
Bought: 0Sold: 324.8K
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 2,098 | $13.39 | $28,097.26 | -17.0% | +36.5% | - | |
| May 2, 2025 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 1,930 | $16.45 | $31,756.61 | -22.8% | -15.7% | +81.0% | |
| Sep 23, 2024 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 70,922 | $28.15 | $1,996,574.40 | -91.6% | +13.2% | -43.0% | |
| May 2, 2024 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 1,956 | $18.91 | $36,987.96 | -37.6% | -11.7% | -12.3% | |
| Feb 9, 2024 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 29,835 | $20.00 | $596,805.46 | -100% | +2.7% | +35.4% | |
| Dec 27, 2023 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sell | 8,497 | $10.50 | $89,218.50 | -100% | +41.7% | +145.1% | |
| May 2, 2023 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 1,897 | $8.90 | $16,892.60 | -22.4% | -16.7% | +117.3% | |
| Oct 3, 2022 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 4,730 | $9.76 | $46,154.87 | -61.2% | -9.6% | -40.1% | |
| Sep 6, 2022 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 4,730 | $10.91 | $51,597.72 | -36.2% | -15.8% | -38.1% | |
| Aug 3, 2022 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 9,232 | $9.31 | $85,921.30 | -75.5% | +2.6% | -28.8% |
Page 1Next →